351 related articles for article (PubMed ID: 33592454)
1. Probiotics: A potential immunomodulator in COVID-19 infection management.
Singh K; Rao A
Nutr Res; 2021 Mar; 87():1-12. PubMed ID: 33592454
[TBL] [Abstract][Full Text] [Related]
2. The immunomodulatory effects of probiotics on respiratory viral infections: A hint for COVID-19 treatment?
Mahooti M; Miri SM; Abdolalipour E; Ghaemi A
Microb Pathog; 2020 Nov; 148():104452. PubMed ID: 32818576
[TBL] [Abstract][Full Text] [Related]
3. Role of probiotics to combat viral infections with emphasis on COVID-19.
Sundararaman A; Ray M; Ravindra PV; Halami PM
Appl Microbiol Biotechnol; 2020 Oct; 104(19):8089-8104. PubMed ID: 32813065
[TBL] [Abstract][Full Text] [Related]
4. Effect of probiotics as an immune modulator for the management of COVID-19.
Ray M; Manjunath A; Halami PM
Arch Microbiol; 2023 Apr; 205(5):182. PubMed ID: 37031431
[TBL] [Abstract][Full Text] [Related]
5. The emerging role of probiotics as a mitigation strategy against coronavirus disease 2019 (COVID-19).
Mirzaei R; Attar A; Papizadeh S; Jeda AS; Hosseini-Fard SR; Jamasbi E; Kazemi S; Amerkani S; Talei GR; Moradi P; Jalalifar S; Yousefimashouf R; Hossain MA; Keyvani H; Karampoor S
Arch Virol; 2021 Jul; 166(7):1819-1840. PubMed ID: 33745067
[TBL] [Abstract][Full Text] [Related]
6. Probiotics-Derived Peptides and Their Immunomodulatory Molecules Can Play a Preventive Role Against Viral Diseases Including COVID-19.
Manna S; Chowdhury T; Chakraborty R; Mandal SM
Probiotics Antimicrob Proteins; 2021 Jun; 13(3):611-623. PubMed ID: 33226581
[TBL] [Abstract][Full Text] [Related]
7. Coronavirus disease 2019 (COVID-19): An overview of the immunopathology, serological diagnosis and management.
Anka AU; Tahir MI; Abubakar SD; Alsabbagh M; Zian Z; Hamedifar H; Sabzevari A; Azizi G
Scand J Immunol; 2021 Apr; 93(4):e12998. PubMed ID: 33190302
[TBL] [Abstract][Full Text] [Related]
8. Probiotics/Prebiotics in Viral Respiratory Infections: Implication for Emerging Pathogens.
Heidari Z; Tajbakhsh A; Gheibihayat SM; Moattari A; Razban V; Berenjian A; Savardashtaki A; Negahdaripour M
Recent Pat Biotechnol; 2021 Oct; 15(2):112-136. PubMed ID: 33874878
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 multifaceted interaction with human host. Part I: What we have learnt and done so far, and the still unknown realities.
Delcuve GP; Lakowski TM; Su RC; Beacon TH; Davie JR
IUBMB Life; 2020 Nov; 72(11):2313-2330. PubMed ID: 32918855
[TBL] [Abstract][Full Text] [Related]
10. Systematic Network and Meta-analysis on the Antiviral Mechanisms of Probiotics: A Preventive and Treatment Strategy to Mitigate SARS-CoV-2 Infection.
Patra S; Saxena S; Sahu N; Pradhan B; Roychowdhury A
Probiotics Antimicrob Proteins; 2021 Aug; 13(4):1138-1156. PubMed ID: 33537958
[TBL] [Abstract][Full Text] [Related]
11. Could nutritional supplements act as therapeutic adjuvants in COVID-19?
Costagliola G; Spada E; Comberiati P; Peroni DG
Ital J Pediatr; 2021 Feb; 47(1):32. PubMed ID: 33588905
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory agents as potential therapeutic or preventive strategies for COVID-19.
Gaziano R; Pistoia ES; Campione E; Fontana C; Marino D; Favaro M; Pica F; Di Francesco P
Eur Rev Med Pharmacol Sci; 2021 Jun; 25(11):4174-4184. PubMed ID: 34156699
[TBL] [Abstract][Full Text] [Related]
13. The effect of probiotics on respiratory tract infection with special emphasis on COVID-19: Systemic review 2010-20.
Darbandi A; Asadi A; Ghanavati R; Afifirad R; Darb Emamie A; Kakanj M; Talebi M
Int J Infect Dis; 2021 Apr; 105():91-104. PubMed ID: 33578007
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulatory and Antiviral Activity of Metformin and Its Potential Implications in Treating Coronavirus Disease 2019 and Lung Injury.
Chen X; Guo H; Qiu L; Zhang C; Deng Q; Leng Q
Front Immunol; 2020; 11():2056. PubMed ID: 32973814
[TBL] [Abstract][Full Text] [Related]
15. Probiotics in Treatment of Viral Respiratory Infections and Neuroinflammatory Disorders.
Shahbazi R; Yasavoli-Sharahi H; Alsadi N; Ismail N; Matar C
Molecules; 2020 Oct; 25(21):. PubMed ID: 33105830
[TBL] [Abstract][Full Text] [Related]
16. Probiotics as a biotherapeutics for the management and prevention of respiratory tract diseases.
Debnath N; Kumar A; Yadav AK
Microbiol Immunol; 2022 Jun; 66(6):277-291. PubMed ID: 35462444
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants.
Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
Microbiol Spectr; 2022 Feb; 10(1):e0150421. PubMed ID: 34985303
[TBL] [Abstract][Full Text] [Related]
18. Probiotics: A gut response to the COVID-19 pandemic but what does the evidence show?
Brahma S; Naik A; Lordan R
Clin Nutr ESPEN; 2022 Oct; 51():17-27. PubMed ID: 36184201
[TBL] [Abstract][Full Text] [Related]
19. Quercetin and Vitamin C: An Experimental, Synergistic Therapy for the Prevention and Treatment of SARS-CoV-2 Related Disease (COVID-19).
Colunga Biancatelli RML; Berrill M; Catravas JD; Marik PE
Front Immunol; 2020; 11():1451. PubMed ID: 32636851
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.
Sanders JM; Monogue ML; Jodlowski TZ; Cutrell JB
JAMA; 2020 May; 323(18):1824-1836. PubMed ID: 32282022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
